Belinda Kingston

733 total citations
11 papers, 91 citations indexed

About

Belinda Kingston is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Belinda Kingston has authored 11 papers receiving a total of 91 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 6 papers in Oncology and 3 papers in Genetics. Recurrent topics in Belinda Kingston's work include Advanced Breast Cancer Therapies (6 papers), HER2/EGFR in Cancer Research (3 papers) and Estrogen and related hormone effects (3 papers). Belinda Kingston is often cited by papers focused on Advanced Breast Cancer Therapies (6 papers), HER2/EGFR in Cancer Research (3 papers) and Estrogen and related hormone effects (3 papers). Belinda Kingston collaborates with scholars based in United Kingdom, United States and France. Belinda Kingston's co-authors include Nicholas C. Turner, Alistair Ring, Alex Pearson, Stephen Johnston, Laura Moretti, María Teresa Herrera-Abreu, Ian Smith, Mary Claire O’Brien, Stefania Redana and Alicia Okines and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Cancer Discovery.

In The Last Decade

Belinda Kingston

10 papers receiving 90 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Belinda Kingston United Kingdom 5 66 56 28 23 18 11 91
Maria Jose Lechuga Frean France 3 107 1.6× 91 1.6× 20 0.7× 20 0.9× 58 3.2× 3 128
Nicolas Madranges France 7 39 0.6× 69 1.2× 13 0.5× 15 0.7× 22 1.2× 11 81
M. De Laurentis Italy 3 66 1.0× 68 1.2× 12 0.4× 29 1.3× 62 3.4× 4 126
Kailey J. Kowalski United States 3 63 1.0× 53 0.9× 15 0.5× 60 2.6× 29 1.6× 7 112
Nikola Vasev Austria 3 90 1.4× 100 1.8× 17 0.6× 20 0.9× 15 0.8× 6 123
Edward Y. Zhu United States 5 26 0.4× 28 0.5× 11 0.4× 16 0.7× 24 1.3× 13 73
Quentin Campbell‐Hewson United Kingdom 5 54 0.8× 56 1.0× 7 0.3× 33 1.4× 17 0.9× 13 101
Michel Velez United States 6 50 0.8× 54 1.0× 7 0.3× 71 3.1× 24 1.3× 16 110
S. Mondal United States 3 91 1.4× 79 1.4× 23 0.8× 9 0.4× 39 2.2× 7 98
Sandeep H. Mashru United States 4 55 0.8× 71 1.3× 11 0.4× 26 1.1× 21 1.2× 7 96

Countries citing papers authored by Belinda Kingston

Since Specialization
Citations

This map shows the geographic impact of Belinda Kingston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Belinda Kingston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Belinda Kingston more than expected).

Fields of papers citing papers by Belinda Kingston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Belinda Kingston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Belinda Kingston. The network helps show where Belinda Kingston may publish in the future.

Co-authorship network of co-authors of Belinda Kingston

This figure shows the co-authorship network connecting the top 25 collaborators of Belinda Kingston. A scholar is included among the top collaborators of Belinda Kingston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Belinda Kingston. Belinda Kingston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Kingston, Belinda, Alex Pearson, María Teresa Herrera-Abreu, et al.. (2023). ESR1 F404 Mutations and Acquired Resistance to Fulvestrant in ESR1 -Mutant Breast Cancer. Cancer Discovery. 14(2). 274–289. 21 indexed citations
2.
Kingston, Belinda, Alex Pearson, María Teresa Herrera-Abreu, et al.. (2022). ESR1 F404 mutations and acquired resistance to fulvestrant in the plasmaMATCH study.. Journal of Clinical Oncology. 40(16_suppl). 1009–1009. 5 indexed citations
3.
Kingston, Belinda, Hannah Bye, Michael Hubank, et al.. (2020). Abstract GS3-07: The genomic landscape of breast cancer based on ctDNA analysis: Data from the plasmaMATCH trial. Cancer Research. 80(4_Supplement). GS3–7. 3 indexed citations
4.
Macpherson, Iain R., Lucy Kilburn, Sarah Kernaghan, et al.. (2020). Abstract P1-19-04: Results from plasmaMATCH trial treatment cohort A: A phase II trial of extended-dose fulvestrant in patients with an ESR1 mutation identified via ctDNA screening (CRUK/15/010). Cancer Research. 80(4_Supplement). P1–19. 1 indexed citations
5.
6.
Battisti, Nicolò Matteo Luca, Belinda Kingston, Judy King, et al.. (2019). Palbociclib and endocrine therapy in heavily pretreated hormone receptor-positive HER2-negative advanced breast cancer: the UK Compassionate Access Programme experience. Breast Cancer Research and Treatment. 174(3). 731–740. 15 indexed citations
7.
Battisti, Nicolò Matteo Luca, Belinda Kingston, James P. King, et al.. (2019). Abstract P6-18-23: Palbociclib and endocrine therapy in fourth line and beyond for hormone receptor-positive HER2-negative advanced breast cancer: The UK compassionate access program experience. Cancer Research. 79(4_Supplement). P6–18. 1 indexed citations
8.
Kingston, Belinda, Caroline Bailleux, Suzette Delaloge, et al.. (2019). Exceptional Response to AKT Inhibition in Patients With Breast Cancer and Germline PTEN Mutations. JCO Precision Oncology. 3(3). 1–7. 14 indexed citations
9.
Kingston, Belinda, Stefania Redana, Eleftheria Kalaitzaki, et al.. (2017). Treatment and prognosis of leptomeningeal disease secondary to metastatic breast cancer: A single-centre experience. The Breast. 36. 54–59. 28 indexed citations
10.
11.
Kingston, Belinda & Stephen Johnston. (2016). Novel Treatments in Breast Cancer. 8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maria Jose Lechuga Frean Breakdown of academic impact, for papers by Nicolas Madranges Breakdown of academic impact, for papers by M. De Laurentis Breakdown of academic impact, for papers by Kailey J. Kowalski Breakdown of academic impact, for papers by Nikola Vasev Breakdown of academic impact, for papers by Edward Y. Zhu Breakdown of academic impact, for papers by Quentin Campbell‐Hewson Breakdown of academic impact, for papers by Michel Velez Breakdown of academic impact, for papers by S. Mondal Breakdown of academic impact, for papers by Sandeep H. Mashru
Rankless by CCL
2026